81 related articles for article (PubMed ID: 28327526)
1. Serenoa repens for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Current Evidence and Its Clinical Implications in Naturopathic Medicine.
Ooi SL; Pak SC
J Altern Complement Med; 2017 Aug; 23(8):599-606. PubMed ID: 28436684
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Novara G; Giannarini G; Alcaraz A; Cózar-Olmo JM; Descazeaud A; Montorsi F; Ficarra V
Eur Urol Focus; 2016 Dec; 2(5):553-561. PubMed ID: 28723522
[TBL] [Abstract][Full Text] [Related]
3. Effects of Serenoa repens Alcohol Extract on Benign Prostate Hyperplasia.
Saidi S; Stavridis S; Stankov O; Dohcev S; Panov S
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Sep; 38(2):123-129. PubMed ID: 28991765
[TBL] [Abstract][Full Text] [Related]
4. Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone.
Boeri L; Capogrosso P; Ventimiglia E; Cazzaniga W; Pederzoli F; Moretti D; Dehò F; Montanari E; Montorsi F; Salonia A
Sci Rep; 2017 Nov; 7(1):15179. PubMed ID: 29123161
[TBL] [Abstract][Full Text] [Related]
5. Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non-inferiority, open-label, clinical study (SPRITE study).
Morgia G; Vespasiani G; Pareo RM; Voce S; Madonia M; Carini M; Ingrassia A; Terrone C; Gentile M; Carrino M; Giannantoni A; Blefari F; Arnone S; Santelli G; Russo GI;
BJU Int; 2018 Aug; 122(2):317-325. PubMed ID: 29569389
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis/chronic pelvic pain syndrome: A randomized clinical trial.
Giammusso B; Di Mauro R; Bernardini R
Arch Ital Urol Androl; 2017 Mar; 89(1):17-21. PubMed ID: 28403589
[TBL] [Abstract][Full Text] [Related]
7. Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients.
Kim SJ; Shin IS; Eun SJ; Whangbo TK; Kim JW; Cho YS; Kim JC
Int Neurourol J; 2017 Mar; 21(1):29-37. PubMed ID: 28361519
[TBL] [Abstract][Full Text] [Related]
8. Association between selenium and lycopene supplementation and incidence of prostate cancer: Results from the post-hoc analysis of the procomb trial.
Morgia G; Voce S; Palmieri F; Gentile M; Iapicca G; Giannantoni A; Blefari F; Carini M; Vespasiani G; Santelli G; Arnone S; Pareo RM; Russo GI
Phytomedicine; 2017 Oct; 34():1-5. PubMed ID: 28899491
[TBL] [Abstract][Full Text] [Related]
9. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
[TBL] [Abstract][Full Text] [Related]
10. Lycopene exerts anti-inflammatory effect to inhibit prostate cancer progression.
Jiang LN; Liu YB; Li BH
Asian J Androl; 2018 Sep; 21(1):80-5. PubMed ID: 30198495
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of lycopene in the treatment of benign prostatic hyperplasia with lower urinary tract symptoms].
Li YZ; Liang WN; Zhang GW; Weng ZQ; Zhong Y; Xu S; Shang XJ
Zhonghua Nan Ke Xue; 2019 Nov; 25(11):1001-1004. PubMed ID: 32233234
[TBL] [Abstract][Full Text] [Related]
12. Lycopene Attenuates Hypoxia-Induced Testicular Injury by Inhibiting PROK2 Expression and Activating PI3K/AKT/mTOR Pathway in a Varicocele Adult Rat.
Wang H; Zhu B; Yu L; Li Q; Li S; Wang P; Jing T; Men T
Evid Based Complement Alternat Med; 2021; 2021():3471356. PubMed ID: 34055003
[TBL] [Abstract][Full Text] [Related]
13. Recent Progress in Discovering the Role of Carotenoids and Metabolites in Prostatic Physiology and Pathology-A Review-Part II: Carotenoids in the Human Studies.
Dulińska-Litewka J; Hałubiec P; Łazarczyk A; Szafrański O; Sharoni Y; McCubrey JA; Gąsiorkiewicz B; Bohn T
Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33672578
[TBL] [Abstract][Full Text] [Related]
14. Survivin and NAIP in Human Benign Prostatic Hyperplasia: Protective Role of the Association of Serenoa repens, Lycopene and Selenium from the Randomized Clinical Study.
Morgia G; Micali A; Rinaldi M; Irrera N; Marini H; Puzzolo D; Pisani A; Privitera S; Russo GI; Cimino S; Ieni A; Trichilo V; Altavilla D; Squadrito F; Minutoli L
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28327526
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene.
Minutoli L; Altavilla D; Marini H; Rinaldi M; Irrera N; Pizzino G; Bitto A; Arena S; Cimino S; Squadrito F; Russo GI; Morgia G
J Biomed Sci; 2014 Mar; 21(1):19. PubMed ID: 24606563
[TBL] [Abstract][Full Text] [Related]
16. Serenoa Repens, lycopene and selenium: a triple therapeutic approach to manage benign prostatic hyperplasia.
Minutoli L; Bitto A; Squadrito F; Marini H; Irrera N; Morgia G; Passantino A; Altavilla D
Curr Med Chem; 2013; 20(10):1306-12. PubMed ID: 23432584
[TBL] [Abstract][Full Text] [Related]
17. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.
Russo A; Capogrosso P; La Croce G; Ventimiglia E; Boeri L; Briganti A; Damiano R; Montorsi F; Salonia A
Expert Opin Drug Saf; 2016 Dec; 15(12):1661-1670. PubMed ID: 27232207
[TBL] [Abstract][Full Text] [Related]
18. Effect of Serenoa repens, lycopene, and selenium on proinflammatory phenotype activation: an in vitro and in vivo comparison study.
Bonvissuto G; Minutoli L; Morgia G; Bitto A; Polito F; Irrera N; Marini H; Squadrito F; Altavilla D
Urology; 2011 Jan; 77(1):248.e9-16. PubMed ID: 21109292
[TBL] [Abstract][Full Text] [Related]
19. [The association of Serenoa repens, lycopene and selenium is superior to Serenoa repens alone in reducing benign prostatic hyperplasia].
Squadrito F; Morgia G
Urologia; 2011; 78(4):297-9. PubMed ID: 21786236
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
